When it comes to investing in pharmaceutical companies, looking at pipelines and research and development prospects is ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Jefferies analyst Akash Tewari increased the price target for Pfizer (NYSE:PFE) shares from $33.00 to $34.00, while ...

A former NYU housing manager is suing the university for religious-based discrimination, claiming he was wrongfully ...

NIH grant recipients receive additional funding to cover "indirect costs," such as building maintenance and administrative ...

On Friday, the U.S. Judicial Panel on Multidistrict Litigation ordered nearly 70 lawsuits be coordinated beefore U.S.

O n Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA vaccines in humans. The bill was sponsored by State Representative Greg Kmetz ...

Pfizer faces stagnant revenue and patent cliffs. Learn why I downgraded PFE stock to Strong Sell despite a 24.7% YoY growth ...

At-home rapid tests for COVID-19 and influenza are becoming available, allowing simultaneous diagnosis, which aids timely and effective treatment and improves patient outcomes.

Eliquis, a blood thinner marketed in partnership with Bristol Myers Squibb, is Pfizer's largest revenue stream at the moment.

Former UK Prime Minister Boris Johnson recently spoke as part of the Society of the Four Arts' Esther B. O’Keeffe Speaker ...

Dr. Paulo H. Verardi, a virologist and head of the Department of Pathobiology and Veterinary Science at the University of ...